Oxygen Therapy Equipment Market Outlook (2022-2033)

Rising Respiratory Burden and the Move Toward Home-Based Care

The primary driver of the Oxygen Therapy Equipment Market is the global increase in chronic respiratory conditions, particularly Chronic Obstructive Pulmonary Disease (COPD), which remains the principal application for these devices. The rising prevalence of COPD, asthma, and sleep apnea, intensified by aging populations and increasing pollution, is a significant factor driving sustained equipment procurement. Additionally, the expansion of home healthcare and remote patient monitoring (RPM) further accelerates market growth, as both patients and payers increasingly prefer home-based oxygen therapy to reduce costs and minimize infection risks. This trend directly increases demand for ultra-portable, user-friendly concentrators. Technological advancements, such as the integration of Internet of Things (IoT) and smart connectivity, also serve as key drivers, enabling real-time data tracking and allowing clinicians to monitor patient adherence and oxygen saturation remotely.

Advancements in battery technology also represent a critical catalyst, as next-generation lithium-sulfur batteries enable ultra-light portable oxygen concentrators (POCs) with run-times exceeding six hours at standard settings. Collectively, these factors, including the increasing prevalence of respiratory diseases, the decentralization of healthcare delivery, and enhanced digital connectivity, support a robust and high-growth trajectory for oxygen therapy solutions.

AI-Native Pulse Delivery and Emerging Market Infrastructure

A significant opportunity exists in the integration of oxygen therapy equipment with artificial intelligence-driven feedback systems. Advanced smart concentrators are being developed with algorithms that automatically adjust oxygen flow in real time according to patient breath rate and physical activity, thereby optimizing therapy and improving battery efficiency. Additionally, the development of non-invasive ventilation (NIV) hybrid systems, which combine oxygen supplementation with pressure support for acute hypercapnic respiratory failure, enables manufacturers to address a wider spectrum of complex clinical requirements within a single device.

The expansion of healthcare infrastructure in emerging economies, particularly in the Asia-Pacific (APAC) and Middle East and Africa (MEA) regions, represents a substantial opportunity as both governmental and private sector investments in oxygen generation plants and backup systems increase to ensure reliable supply in rural clinics. In addition to hardware advancements, the emergence of integrated Device-as-a-Service (DaaS) subscription models allows manufacturers to oversee equipment maintenance and refills for home-based patients, thereby generating consistent and recurring revenue streams. Companies prioritizing noise-optimized whisper technology and pioneering wearable oxygen delivery systems are well positioned to lead the global oxygen therapy equipment market.

The "Oxygen Therapy Equipment Market Size and Forecast (2022–2033)" report provides a detailed analysis of the market covering below areas:

• Oxygen Therapy Equipment market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Oxygen Therapy Equipment market trends, as well as market dynamics such as drivers, restraints, and key opportunities
• Oxygen Therapy Equipment market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Oxygen Therapy Equipment market
• Detailed company profiles, including SWOT analysis

The geographical scope of the Oxygen Therapy Equipment market report is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America remains the leading market due to a high prevalence of respiratory disorders such as COPD and asthma, as well as a comprehensive reimbursement framework that promotes the adoption of home-based oxygen therapy. Europe maintains a significant market share, supported by growing awareness of early respiratory diagnosis and a robust healthcare infrastructure that facilitates integrated chronic disease management. The Asia Pacific region represents the fastest-growing market, driven by rapid urbanization, increasing pollution, and large-scale government initiatives in China and India to enhance medical oxygen infrastructure in response to recent global health challenges.

The Asia-Pacific Oxygen Therapy Equipment Market is segmented into China, Japan, South Korea, India, Australia, and the Rest of Asia Pacific. China serves as a primary growth driver, with domestic manufacturing of oxygen concentrators expanding significantly to address both local and international demand. In India, the home healthcare sector is experiencing rapid growth, and portable oxygen concentrators are increasingly preferred by patients seeking mobility and independence. Japan leads in the development of ultra-lightweight and energy-efficient oxygen systems designed for its aging population. Australia is experiencing greater adoption of IoT-enabled devices for remote patient monitoring. 

• The report includes qualitative and quantitative data in the Oxygen Therapy Equipment market across product, application, end user, and geography.
• The report starts with the key takeaways (chapter 2), highlighting the key trends and outlook of the Oxygen Therapy Equipment market.
• Chapter 3 includes the research methodology of the study.
• Chapter 4 further includes ecosystem analysis.
• Chapter 5 highlights the major industry dynamics in the Oxygen Therapy Equipment market, including factors that are driving the market, prevailing deterrents, potential opportunities, as well as future trends. Impact analysis of these drivers and restraints is also covered in this section.
• Chapter 6 discusses the Oxygen Therapy Equipment market scenario, in terms of historical market revenues, and forecast till the year 2033.
• Chapters 7 to 10 cover Oxygen Therapy Equipment market segments by product, application, end user, and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America. They cover the market revenue, forecast, and factors driving the market.
• Chapter 11 describes the competitive analysis along with the heat map analysis for the key players operating in the market.
• Chapter 12 describes the industry landscape analysis. It provides detailed descriptions of business activities such as market initiatives, new developments, mergers, and joint ventures globally, along with a competitive landscape.
• Chapter 13 provides detailed profiles of the major companies operating in the Oxygen Therapy Equipment market. Companies have been profiled on the basis of their key facts, business descriptions, products and services, financial overview, SWOT analysis, and key developments.
• Chapter 14, i.e., the appendix, is inclusive of a brief overview of the company, list of abbreviations, and disclaimer.

The Oxygen Therapy Equipment market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the Oxygen Therapy Equipment market are:

• In June 2025, Inogen, Inc. launched the Voxi™ 5 Stationary Oxygen Concentrator in the United States, expanding its home oxygen therapy portfolio. Developed in collaboration with Yuwell Medical, the device delivers 1–5 L/min continuous flow oxygen and is designed to enhance affordability, durability, and accessibility for long-term care patients. This launch strengthens Inogen`s position in the homecare oxygen therapy segment and expands its market reach through existing sales channels.
• In January 2025, Inogen, Inc. entered into a strategic collaboration with Yuwell Medical to expand its respiratory product portfolio, strengthen its R&D pipeline, and enhance global market reach. As part of the agreement, Yuwell committed a $27.2 million equity investment in Inogen, supporting expansion in the U.S. and accelerating entry into the Chinese market.